Citrate- vs. acetate-based dialysate in bicarbonate haemodialysis: consequences on haemodynamics, coagulation, acid-base status, and electrolytes.
Data(s) |
2009
|
---|---|
Resumo |
BACKGROUND: A concentrate for bicarbonate haemodialysis acidified with citrate instead of acetate has been marketed in recent years. The small amount of citrate used (one-fifth of the concentration adopted in regional anticoagulation) protects against intradialyser clotting while minimally affecting the calcium concentration. The aim of this study was to compare the impact of citrate- and acetate-based dialysates on systemic haemodynamics, coagulation, acid-base status, calcium balance and dialysis efficiency. METHODS: In 25 patients who underwent a total of 375 dialysis sessions, an acetate dialysate (A) was compared with a citrate dialysate with (C+) or without (C) calcium supplementation (0.25 mmol/L) in a randomised single-blind cross-over study. Systemic haemodynamics were evaluated using pulse-wave analysis. Coagulation, acid-base status, calcium balance and dialysis efficiency were assessed using standard biochemical markers. RESULTS: Patients receiving the citrate dialysate had significantly lower systolic blood pressure (BP) (-4.3 mmHg, p < 0.01) and peripheral resistances (PR) (-51 dyne.sec.cm-5, p < 0.001) while stroke volume was not increased. In hypertensive patients there was a substantial reduction in BP (-7.8 mmHg, p < 0.01). With the C+ dialysate the BP gap was less pronounced but the reduction in PR was even greater (-226 dyne.sec.cm-5, p < 0.001). Analyses of the fluctuations in PR and of subjective tolerance suggested improved haemodynamic stability with the citrate dialysate. Furthermore, an increase in pre-dialysis bicarbonate and a decrease in pre-dialysis BUN, post-dialysis phosphate and ionised calcium were noted. Systemic coagulation activation was not influenced by citrate. CONCLUSION: The positive impact on dialysis efficiency, acid-base status and haemodynamics, as well as the subjective tolerance, together indicate that citrate dialysate can significantly contribute to improving haemodialysis in selected patients. |
Identificador |
https://serval.unil.ch/?id=serval:BIB_82D7A3B4291F isbn:1471-2369[electronic], 1471-2369[linking] pmid:19265544 doi:10.1186/1471-2369-10-7 isiid:000283019300001 http://my.unil.ch/serval/document/BIB_82D7A3B4291F.pdf http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_82D7A3B4291F1 |
Idioma(s) |
en |
Direitos |
info:eu-repo/semantics/openAccess |
Fonte |
BMC Nephrology, vol. 10, pp. 7 |
Palavras-Chave | #Acetates/administration & dosage; Acetates/pharmacology; Acid-Base Equilibrium/drug effects; Aged; Aged, 80 and over; Bicarbonates/administration & dosage; Blood Coagulation/drug effects; Blood Urea Nitrogen; Calcium/administration & dosage; Calcium/blood; Citric Acid/administration & dosage; Citric Acid/pharmacology; Cross-Over Studies; Electrolytes/blood; Female; Hemodialysis Solutions/pharmacology; Hemodynamics/drug effects; Humans; Male; Middle Aged; Phosphates/blood; Renal Dialysis/methods; Single-Blind Method |
Tipo |
info:eu-repo/semantics/article article |